NasdaqGS - Delayed Quote • USD
Abiomed, Inc. (ABMD)
At close: December 21 at 4:00 PM EST
Breakdown
TTM
3/31/2022
3/31/2021
Total Revenue
1,074,096.00
1,031,753.00
847,522.00
Cost of Revenue
200,590.00
188,158.00
161,907.00
Gross Profit
873,506.00
843,595.00
685,615.00
Operating Expense
619,397.00
586,889.00
456,058.00
Operating Income
254,109.00
256,706.00
229,557.00
Net Non Operating Interest Income Expense
87,551.00
49,840.00
--
Other Income Expense
--
-115,986.00
58,663.00
Pretax Income
341,164.00
190,560.00
288,220.00
Tax Provision
74,400.00
54,055.00
62,695.00
Net Income Common Stockholders
266,764.00
136,505.00
225,525.00
Diluted NI Available to Com Stockholders
266,764.00
136,505.00
225,525.00
Basic EPS
--
3.00
5.00
Diluted EPS
--
2.98
4.94
Basic Average Shares
--
45,445.00
45,140.00
Diluted Average Shares
--
45,881.00
45,674.00
Total Operating Income as Reported
253,613.00
140,720.00
229,557.00
Total Expenses
819,987.00
775,047.00
617,965.00
Net Income from Continuing & Discontinued Operation
266,764.00
136,505.00
225,525.00
Normalized Income
267,151.83
219,550.98
220,272.31
Interest Income
87,551.00
49,840.00
--
Net Interest Income
87,551.00
49,840.00
--
EBIT
254,109.00
256,706.00
229,557.00
EBITDA
281,669.00
284,795.00
253,654.00
Reconciled Cost of Revenue
200,590.00
188,158.00
161,907.00
Reconciled Depreciation
27,560.00
28,089.00
24,097.00
Net Income from Continuing Operation Net Minority Interest
266,764.00
136,505.00
225,525.00
Total Unusual Items Excluding Goodwill
-496.00
-115,986.00
6,717.00
Total Unusual Items
-496.00
-115,986.00
6,717.00
Normalized EBITDA
282,165.00
400,781.00
246,937.00
Tax Rate for Calcs
0.00
0.00
0.00
Tax Effect of Unusual Items
-108.17
-32,940.02
1,464.31
3/31/2021 - 7/29/1987
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade